Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$281,106
+$68,567 QoQ
Shares Held
2,225
+45.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,692
of 2,266 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Congress Park Capital LLC holds $10,199,729 across 8 Drug Manufacturers - General names. GILD ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,607 | $4,326,344 | |
| 2 | AMGN |
Amgen Inc
|
5,130 | $1,857,675 | |
| 3 | JNJ |
Johnson & Johnson
|
6,838 | $1,736,646 | |
| 4 | ABBV |
AbbVie Inc.
|
3,637 | $915,214 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,060 | $650,210 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,225 | $281,106 | |
| 7 | PFE |
Pfizer Inc
|
9,551 | $229,988 | |
| 8 | NVO |
Novo Nordisk A S
|
4,225 | $202,546 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,106 | 2,225 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $212,539 | 1,525 | Shares | Sole | 2026-04-14 | |
| 2021-12-31 | $235,982 | 3,250 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $227,012 | 3,250 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $223,795 | 3,250 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $210,047 | 3,250 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||